A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy Patients
Clinical trial NCT07767890 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07767890
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-10-30
- Primary completion
- 2031-03-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.